LimmaTech Biologics AG’s Post

View organization page for LimmaTech Biologics AG, graphic

3,738 followers

During #STIAwarenessWeek, we want to raise the awareness that anyone can be affected by sexually transmitted diseases. Did you know that gonorrhea is the second most common sexually transmitted disease with approximately 700,000 infections each year in the U.S. alone? Although gonorrhea can be treated with antibiotics, over the past 80 years the bacterium that causes the disease, Neisseria gonorrhoeae, has become resistant to nearly all available antimicrobial treatments. Today, there is only one recommended treatment option while the number of treatment failures and local outbreaks has been growing in several countries.   Therefore, prevention is the best protection to maintain sexual and reproductive health. At LimmaTech, we are dedicated to creating prophylactic vaccines that can deliver transformative value worldwide by preventing microbial infections as well as combating the rising threat of AMR.   Learn more here: www.lmtbio.com   #TalkTestTreat #vaccines

  • No alternative text description for this image
Giody Bartolomei

8+ Years of Excellence in Operations & Project Management | Biotechnology & UPS | Vaccine development| Protein biology

6mo

Indeed, there is a growing risk of gonorrhea becoming untreatable. That calls for a potent vaccine strategy! Great appreciation for your efforts.

Like
Reply

To view or add a comment, sign in

Explore topics